3rd Mastering HR Summit 2012

North West Business Group22 - 23 February 2012, Istanbul, Turkey.
The role of Human Resources is changing as fast as technology and the global marketplace. Historically, the HR department was viewed as administrative overhead.

HR processed payroll, handled benefits administration, kept personnel files and other records, managed the hiring process, and provided other administrative support to the business. Those times have changed. The positive result of these changes is that HR professionals have the opportunity to play a more strategic role in the business. The challenge for HR managers is to keep up to date with the latest HR innovations - technological, legal, and otherwise.

The 3rd Mastering HR Summit 2012 will discuss the best practices in HR management, in other words how HR managers can anticipate and address some of the most challenging HR issues this year.

The event will give you the information you need to know about these current HR challenges and how to most effectively manage them in your workplace. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • Inclusive Talent Management as an enabler of business turnaround
  • How Connecting Performance Management & Talent is going to help you?
  • New perspectives for very experienced persons (VEPs)
  • Working with an HR Strategy to ensure employee retention & effective performance
  • Managing Talent from different cultures with a global model
  • How to connect HR investments to the firm's bottom line
  • HR Transformation and engagement - Business case
  • TQM Tools for employee empowerment
  • Motivation and benefit systems and their impact on performance - a critical view
  • How to set the strategic agenda for Human Resources

Joins some of the experts like:

  • President EAPM, Secretary General WFPMA
  • The Hertz Corporation, Vice President - Global Talent Management
  • Tetra Pak, VP Human Resources, Packaging Solutions & Cluster Coordination
  • Medtronic, Vice President Human Resources Europe & Central Asia
  • Ericsson, Vice President Human Resources & Organization
  • Beiersdorf AG, Regional HR Vice President, Asia and Australia
  • Schneider Electric France, HR Vice President Country Partner
  • Papyrus Group, Senior Vice President Human Resources
  • Citi, Senior Vice President Human Resources EMEA Consumer
  • Mercedes-Benz, General Manager – Business Support
  • Swisscom, Head Group Talent Management
  • Vodafone, Human Resources Director
  • BNP Paribas, Head of UK Recruitment & European Campus Recruitment
  • Eczacıbaşı Holding, HR Director, Corporate Human Resources
  • Gulf Bridge International, Director of HR & Corporate Planning
  • Abdiibrahim, HR Manager
  • TÜV SÜD, Former Head of Division Academy
  • And many more...

Hear from experts actively working in the industry for corporates;

  • Employing close to 1 million people.
  • Operating in more than 250 countries.
  • Presented in 6 continents.
  • With 191€ billion in revenue (2010).

This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

After this two day conference, you will be empowered to lead your HR team as a true strategic partner that will improve your organization's competitive advantages and sustainability.

For further information and registration, please visit:
http://nwbg.eu/all-events/3rd-master-hr-sumit-2011/

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

Pfizer receives FDA approval for SUTENT® (sunitini…

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

Efficacy and safety maintained in patients who swi…

Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA, a pivotal Phase III clinical trial comparing Cyltezo® (adalimumab-adbm) and reference product Humira...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]